Almac’s Singapore facility secures GMP Certification
07 Nov 2024 //
PRESS RELEASE
Almac Pharma Services Announces Recruitment Event At HQ
28 Oct 2024 //
PRESS RELEASE
Almac Chemist Recognised As "Future Leader" At CPHI Awards
09 Oct 2024 //
PRESS RELEASE
Almac Group Announces £11m Investment For Global Services
01 Oct 2024 //
PRESS RELEASE
Almac Invests £11M to Expand Global Analytical Services
01 Oct 2024 //
CONTRACT PHARMA
Almac Pharma Services Appoints New VP Finance
30 Sep 2024 //
PRESS RELEASE
Arran Chemical Company celebrates 40 successful years in business
24 Sep 2024 //
PRESS RELEASE
Almac Group North American Headquarters Expansion PV, USA
20 Sep 2024 //
PHARMATECH
Almac Services Joins European Paediatric Formulation Initiative
30 Aug 2024 //
PRESS RELEASE
Almac Announces Investment In Singapore Cold Chain Facility
30 Jul 2024 //
PRESS RELEASE
Almac Announces Investment in Singapore to Enhance Cold Chain Facility
30 Jul 2024 //
PRESS RELEASE
Almac Completes FDA Inspection at Charnwood, UK Facilities
25 Jul 2024 //
CONTRACT PHARMA
Almac Pharma Services Announces Successful FDA Inspection
23 Jul 2024 //
PRESS RELEASE
Almac Group’s Renewable Energy Power Purchase Agreement Goes Live
18 Jul 2024 //
PRESS RELEASE
Almac Pharma Services Supports Rapid Launch of BioLineRx’s APHEXDA motixafortide
18 Jun 2024 //
PRESS RELEASE
Almac Pharma Services Appoints New VP Business Development
04 Jun 2024 //
PRESS RELEASE
Almac Discovery nominates ALM-401 First Class Bispecific Next Generation ADC
30 May 2024 //
PRESS RELEASE
Almac’s 2023 revenue bump; France to invest in easing greenhouse gas impact
30 May 2024 //
ENDPTS
Almac Group announces record revenue figure resulting from another year growth
28 May 2024 //
PRESS RELEASE
Almac Pharma Services Supports Industry Consortium to Address Titanium Dioxide
30 Apr 2024 //
PRESS RELEASE
Amicus Inc & Almac Pharma Services Mark 15-year Strategic Partnership
22 Apr 2024 //
PRESS RELEASE
Almac Clinical celebrates Grace Science in dosing first NGLY1 deficient patien
11 Apr 2024 //
PRESS RELEASE
Almac Pharma Appoints New Director of Manufacturing Science & Technology
04 Apr 2024 //
PRESS RELEASE
Almac Group announces support of ESG category at this year’s Belfast
27 Mar 2024 //
PRESS RELEASE
Tonix Pharmaceuticals Selects 2 CMOs to Support Tonmya in the U.S.
20 Mar 2024 //
CONTRACT PHARMA
Almac Sciences awarded Life Sciences Innovative Manufacturing Fund Grant
14 Mar 2024 //
PRESS RELEASE
Almac Group Awarded six 2024 CDMO Leadership Awards
12 Mar 2024 //
PRESS RELEASE
Almac continues its expansion with completion of 2 facilities
06 Mar 2024 //
FIERCE PHARMA
Almac Pharma Services Renew HPRA GMP Certification for European Facility
12 Feb 2024 //
PRESS RELEASE
Almac Group signs virtual power purchase agreement (VPPA) for renewable energy
06 Feb 2024 //
PRESS RELEASE
Almac Sciences extends select AZyme offering to therapeutic oligonucleotide
25 Jan 2024 //
PRESS RELEASE
Almac Launches Manufacturing and Development Recruitment Drive
15 Jan 2024 //
PRESS RELEASE
Almac Expands Next-Gen Sequencing Capabilities with Illumina NovaSeq X Plus
30 Aug 2023 //
CONTRACT PHARMA
Almac Group Global Workforce Hits 7,000 Employees
07 Jun 2023 //
CONTRACT PHARMA
Almac Group joins Employers for Carers to further support working carers
25 May 2023 //
PRESS RELEASE
Almac Diagnostic updates clara? report with new content for cancer research
17 May 2023 //
PRESS RELEASE
Almac Pharma Services Hosts Recruitment Open Day in Loughborough
12 May 2023 //
PRESS RELEASE
Almac Group Hosts Recruitment Open Day in the North West as 20 new jobs
11 May 2023 //
PRESS RELEASE
Almac Sciences & University College Dublin BROADEN Flow Chemistry Collaboration
04 May 2023 //
PRESS RELEASE
Almac Announces Launch of IXRS®3 Partnership Network
25 Apr 2023 //
PRESS RELEASE
Almac Appoints Global Energy Manager as part of ongoing commitment
21 Apr 2023 //
PRESS RELEASE
Almac Group Receives Product Approval from FDA, MHRA and Health Canada
15 Nov 2022 //
CONTRACTPHARMA
Almac Introduces New Cryogenic Service Solution
05 Oct 2022 //
CONTRACTPHARMA
Almac commits to $65M expansion for its Pennsylvania HQ amid wider investments
18 Aug 2022 //
ENDPTS
Almac Invests $65M to Expand North American HQ
11 Aug 2022 //
THEPHARMALETTER
Almac Group Unveils $250M Global Expansion Plans
15 Jun 2022 //
CONTRACTPHARMA
Almac Invests in NMR Technology to Enhance Analytical Services
12 Apr 2022 //
CONTRACTPHARMA
Almac Sciences, IMR Collaborate to Enhance Flow Chemistry Expertise
04 Nov 2021 //
CONTRACTPHARMA
Exploring ICP-MS expertise at Almac
06 Oct 2021 //
CONTRACTPHARMA
Almac, PILA PHARMA Enter API Manufacturing Pact
11 Aug 2021 //
CONTRACT PHARMA
Almac Expands Crystallization Capabilities
01 Jul 2021 //
CONTRACTPHARMA
Almac Sciences Invests in Continuous Flow Chemistry Equipment
25 May 2021 //
CONTRACTPHARMA
Almac Sciences to Invest in Continuous Flow Chemistry Equipment New R&D Center
25 May 2021 //
PHARMTECH
Almac Group Completes $7M R&D Center
23 Feb 2021 //
CONTRATCTPHARMA
Almac Invests in Expanding Global Biologics Testing Solutions
02 Feb 2021 //
PHARMTECH
Almac Invests in Expanding Global Biologics Testing Solutions
28 Jan 2021 //
PHARMTECH
Almac Sciences Secures Support from Invest NI
14 Jan 2021 //
CONTRACTPHARMA
Almac secures grant to scale COVID-19 drug production
25 Nov 2020 //
OUTSOURCING-PHARMA
Almac appoints Dan Bayston VP of Small Molecule API
07 Oct 2020 //
MANUFACTURING CHEMIST
Almac launches clinical site temperature data tool
06 Jul 2020 //
OUTSOURCING-PHARMA